Mobocertinib and Bevacizumab for Amivantamab-Refractory Lung Cancer With EGFR Exon 20 Insertion Mutation: A Case Report
Article in JTO Clinical and Research Reports (November 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in JTO Clinical and Research Reports (November 2023)
Article in Frontiers in Genetics (April 2023)
Article in Biomedicine & Pharmacotherapy (November 2022)